MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2DP26F9163 is a delivery order issued on August 27, 2026, under the primary contract SPE2DX25D9900. The contract was awarded to DMS Pharmaceutical Group Inc for the procurement of Meloxicam Tablets, identified by NSN 6505015413243 and PR 7018084338. The total contract value is 450.00 dollars, covering a single line item for 10 bottles at a unit price of 45.00 dollars each. This order was facilitated through the DLA Troop Support Medical Supply Chain FSB and is governed by the terms of the commercial items solicitation and contract SPE2DX-25-D-9900, which became effective on April 2, 2025. The agreement includes specific requirements for supply descriptions, product identifiers, and delivery instructions, while adhering to federal regulations including FAR clause 52.222-50 regarding Combating Trafficking in Persons.
General Info
Contract Value
$450Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
